Updated Data Matrix Available

Market Value | Market Volume | Epidemiology | Clinical Trials | Patent Landscape | Regulatory Approvals | COVID-19 Impact Analysis

Global Peripheral Vascular Devices Market $13.5 Billion by 2027

The global market for peripheral vascular devices anticipated to attain $13.5 billion by 2027, expanding at a CAGR of 6.4% over the forecast period, driven by increasing prevalence and incidence of stroke and coronary heart diseases worldwide.

  • Other factors driving the market growth include increasing incidence of peripheral vascular disease, growing elderly population and increasing demand for minimally invasive endovascular procedures.
    • In addition, the wearable fitness monitors and telemonitoring have been used in the community to mobilize patients with peripheral vascular disease with good results.
Global Peripheral Vascular Devices Market

Peripheral vascular disease (PVD), also called peripheral arterial disease (PAD), in which narrowed blood vessels outside the heart cannot deliver enough oxygen and nutrients to the body. PAD is an important circulatory system disorder similar in prevalence to stroke and coronary heart disease.

  • Early peripheral vascular disease detection in the outpatient setting combined with ambulatory follow‐up care could slow disease progression and reduce PAD‐related hospitalizations.
    • PAD can cause chronic wounds on the limbs and increases the risk of heart attack or stroke.
      • There are certain risk factors for peripheral vascular disease growth such as hypertension, high blood pressure, or high cholesterol, obesity, diabetes and smoking.

Depending on the severity of the condition, treatment options may range from managing risk factors (through lifestyle changes and medications) to procedures or surgery to improve blood flow. 

  • Drug therapy for patients with PVD includes several options to improve blood flow, such as antiplatelet agents (blood thinners) and medicines such as intra-arterial thrombolytic drugs (urokinase [Abbokinase]) that relax the blood vessel walls.
    • Surgical  treatment options include angioplasty (endovascular stenting,  balloon angioplasty, atherectomy, laser angioplasty)and bypass grafting.

Currently, there is a lack of good quality, comparative evidence to guide clinical practice on many of the new endovascular technologies used to treat PAD.

  • Many new devices, and new generations of older devices, are now available for less invasive, endovascular treatment of PAD.
    • The peripheral vascular device market is complex, encompassing numerous procedures such as vascular stenting, atherectomy, chronic total occlusion repair, transcatheter embolization and vena cava filter implantation.
Peripheral Vascular Devices (PVD) Market

The global peripheral vascular devices market report provides market size ($million 2017 to 2027), market share, growth trends and forecast (CAGR%, 2021 to 2027). 

The global market for peripheral vascular devices segmented by product [peripheral vascular stents (fem-pop stents, iliac artery, renal artery, carotid artery), peripheral transluminal angioplasty balloon catheters, PTA guidewires, atherectomy devices (rotational atherectomy devices, orbital atherectomy devices, directional atherectomy devices, laser atherectomy devices), chronic total occlusion devices, aortic stents, synthetic surgical grafts, embolic protection devices (balloon occlusion devices, catheter occlusion devices, filter devices), inferior vena cava filters (retrievable filters, permanent IVC filters)], and geography.

  • Increasing awareness and diagnosis of peripheral artery disease along with the introduction of improved devices is driving an annual growth rate of this market.
    • Many new devices, and new generations of older devices, are now available for less invasive, endovascular treatment of PAD.
      • Minimally invasive endovascular treatments to expand the opening of the artery, such as angioplasty or atherectomy, are now used more often than bypass surgery as the initial treatment approach for PAD.
        • Increasingly, balloon angioplasty with stenting (percutaneous transluminal angioplasty) is used in conjunction with other therapies and less as a standalone treatment.
        • Atherectomy may be used alone, or in combination with balloon angioplasty, to facilitate the placement of stents or to improve patency without using a stent, or to improve drug absorption by removing plaque before the use of angioplasty and drug-coated balloons.
          • Many different atherectomy devices are commercially available.
  • Based on the products, the peripheral vascular stents segment accounted for the largest share of total market, while the Fem-pop stents sub-segment dominated the total peripheral vascular stents market.
    • Peripheral angioplasty, a minimally invasive procedure has emerged as a preferred choice for the treatment of PVD.
    • Higher incidence of lifestyle diseases such as diabetes and obesity leading to PVD is boosting the demand for peripheral vascular stents.
  • However, the embolic protection devices segment predicted to register the fastest growth rate during the forecast period, where the balloon occlusion devices sub-segment dominated the embolization products market.
    • Embolic protection devices aim to reduce the occurrence of emboli in the brain, thereby reducing the risk of postoperative neurological defects in patient during the surgery.
  • The atherectomy devices have continued to emerge as a major therapy in the management of peripheral vascular disease. 

The global market for peripheral vascular products research report is further divided by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA), and Rest of the World.

  • The epidemiology for different patterns of PAD (carotid artery disease, upper extremity artery disease, mesenteric artery disease, renal artery disease and lower extremity artery disease) are varied depending on population.
    • It is estimated that >230 million people have PAD worldwide, with a spectrum of symptoms from none to severe.
      • Relatively uncommon among younger people, the prevalence of PAD rises with age and affects a substantial proportion of the elderly population.
  • In terms of geography, the North America peripheral vascular devices market held the majority share of the total market, followed by the Europe region, owing to increasing aging population, technological improvements, and rising prevalence of chronic diseases such as high blood pressure, diabetes and obesity in developed countries.
    • The prevalence of PAD in the United States is estimated to be ~7%, affecting 8.5 million adults. Both men and woman are affected by PAD; however, African Americans have an increased risk of PAD. 
    • The prevalence of PAD on the European continent has been estimated at 5.3% (40 million people), while that in the European Union (EU) has been estimated at 3.4% (17 million patients).
  • On the other hand, the Asia Pacific market expected to grow at the fastest CAGR during the coming years, attributed to increasing healthcare awareness, economic development and high prevalence of PAD in emerging countries.
    • It was estimated that 70% of the 202 million people living with PAD were residing in low to middle-income countries in 2010. This includes 54.8 million PAD patients in Southeast Asia and 45.9 million in the Western Pacific region.

The global market research report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.

Major competitors operating in the global market for peripheral vascular products and included in this report are Abbott Laboratories, Inc., AngioScore, Inc., Becton, Dickinson and Company (C.R. Bard, Inc.), Boston Scientific Corporation, Cardinal Health (Cordis Corporation), Cook Group, Inc., Edward Lifesciences Corporation, Koninklijke Philips N.V. (Volcano Corporation), and Medtronic plc (Covidien plc).

  • Product
    • Peripheral Vascular Stents
      • Fem-pop Stents
      • Iliac Artery
      • Renal Artery
      • Carotid Artery
    • Peripheral Transluminal Angioplasty (PTA) Balloon Catheters
    • Peripheral Transluminal Angioplasty (PTA) Guidewires
    • Atherectomy Devices
      • Rotational Atherectomy Devices
      • Orbital Atherectomy Devices
      • Directional Atherectomy Devices
      • Laser Atherectomy Devices
    • Chronic Total Occlusion (CTO) Devices
    • Aortic Stents
    • Synthetic Surgical Grafts
    • Embolic Protection Devices
      • Balloon Occlusion Devices
      • Catheter Occlusion Devices
      • Filter Devices
    • Inferior Vena Cava Filters
      • Retrievable Filters
      • Permanent IVC Filters
  • Geography
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Rest of the World
  • Company Profiles
    • Abbott Laboratories, Inc.
    • AngioScore, Inc.
    • Becton, Dickinson and Company (C.R. Bard, Inc.)
    • Boston Scientific Corporation
    • Cardinal Health (Cordis Corporation)
    • Cook Group, Inc.
    • Edward Lifesciences Corporation
    • Koninklijke Philips N.V. (Volcano Corporation)
    • Medtronic plc (Covidien plc)

To request Table of Contents and Sample Pages of this report visit:

Related publications:

    Request ToC/Sample information for this market analysis

    Full Name*

    Company Email*

    Phone Number* [Please add country code]



    Secure Online Payment

    iHealthcareAnalyst, Inc.

    Contact Address

    US Office: 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043, United States
    Phone: +1 (314) 315-4764
    India Office: 5, Shilpa Chambers, Opp. J. M. Road, Shivajinager, Pune 411005, India
    Phone: +91 (20) 25898524
    Email: [email protected]